Tempus AI, Inc. (BMV:TEM)

Market Cap	195.31B
Revenue (ttm)	17.95B
Net Income (ttm)	-3.77B
Shares Out	n/a
EPS (ttm)	-22.24
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,285
Average Volume	3,637
Open	1,127.00
Previous Close	1,100.00
Day's Range	1,110.00 - 1,200.00
52-Week Range	796.50 - 1,890.00
Beta	n/a
RSI	50.97
Earnings Date	Aug 6, 2025

About Paramount Global

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharma...

• Industry: Medical Laboratories
• Founded: 2015
• Employees: 2,400
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: TEM

Financial Performance

In 2024, Tempus AI's revenue was $693.40 million, an increase of 30.38% compared to the previous year's $531.82 million. Losses were -$746.33 million, 180.6% more than in 2023.